Improved Estimation of GFR by Cystatin C in Preventing Contrast Induced Nephropathy by NAC or Zn

NCT00399256 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Failure

Interventions

DRUG: Acetylcysteine
DRUG: Zinc

Sponsor

Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)